No CrossRef data available.
Article contents
Development and implementation of the Antimicrobial Stewardship Intervention Scoring Tool at a single pediatric institution
Published online by Cambridge University Press: 16 September 2024
Abstract
Objective:
The primary objective was to grade the potential impact of antimicrobial stewardship program (ASP) interventions on patient safety at a single center using a newly developed scoring tool, the Antimicrobial Stewardship Impact Scoring Tool (ASIST).
Design:
Retrospective descriptive study.
Setting:
A 367-bed free-standing, pediatric academic medical center.
Methods:
The ASP team developed the ASIST which scored each intervention on an impact level (low, moderate, high) based on patient harm avoidance and degree of antibiotic optimization. Intervention frequency and characteristics were collected between May 1, 2022 and October 31, 2023. Intervention rates per impact level were calculated monthly.
Results:
The ASP team made 1024 interventions further classified as low (45.1%), moderate (47%), and high impact (7.9%). The interventions for general pediatrics (53.9%) and those to modify formulation (62.2%), dose/frequency (58.1%), and duration (57.5%) were frequently low impact. Hematology/oncology (12.5%), sub-specialty (11.7%), and surgical services (11.3%) had the greatest rate of high-impact interventions. Interventions to broaden antibiotics (40.8%) and those associated with antibiotics used to treat bacteremia (20.6%) were frequently classified as high-impact.
Conclusion:
The ASIST is an effective tool to link ASP interventions to prevention of antimicrobial-associated patient harm. For our ASP team, it provided meaningful data to present to hospital leadership and identified opportunities to prevent future harm and reduce ASP team workload.
- Type
- Original Article
- Information
- Copyright
- © The Author(s), 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
References
Bauer, KA, Kullar, R, Gilchrist, M, File, TM. Antibiotics and adverse events: the role of antimicrobial stewardship programs in ‘doing no harm’. Curr Opin Infect Dis 2019;32:553–558.Google Scholar
Shehab, N, Patel, PR, Srinivasan, A, Budnitz, DS. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis 2008;47:735–743.Google Scholar
Tamma, PD, Avdic, E, Li, DX, Dzintars, K, Cosgrove, SE. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med 2017;177:1308–1315.Google Scholar
Butler, AM, Brown, DS, Durkin, MJ, et al. Association of inappropriate outpatient pediatric antibiotic prescriptions with adverse drug events and health care expenditures. JAMA Netw Open 2022;5:e2214153.Google Scholar
Same, RG, Hsu, AJ, Cosgrove, SE, et al. Antibiotic-associated adverse events in hospitalized children. J Pediatric Infect Dis Soc 2021;10:622–628.Google Scholar
Tamma, P, Holmes, A, Ashley, ED. Antimicrobial stewardship: another focus for patient safety?. Curr Opin Infect Dis 2014;27:348–355.Google Scholar
Searns, JB, Williams, MC, MacBrayne, CE, et al. Handshake antimicrobial stewardship as a model to recognize and prevent diagnostic errors. Diagnosis (Berl) 2020; 8:347–352.Google Scholar
Patel, S, Vazquez, JA, Chase, A, Ebong, E. 89. A collaborative & novel antimicrobial stewardship initiative – mandatory approval of peripherally inserted central venous catheters. Open Forum Infect Dis 2020;7:S60–S61.Google Scholar
Tamma, PD, Miller, MA, Dullabh, P, et al. Association of a safety program for improving antibiotic use with antibiotic use and hospital-onset Clostridioides difficile infection rates among US hospitals. JAMA Netw Open 2021;4:e210235.Google Scholar
Hurtado, D, Varela, M, Juarez, A, Nguyen, Y-N, Nhean, S. Impact of antimicrobial stewardship program intervention acceptance on hospital length of stay. Hosp Pharm 2023;58:491–495.Google Scholar
The core elements of hospital antibiotic stewardship programs: 2019. Center for Disease Control and Prevention website. https://www.cdc.gov/antibiotic-use/healthcare/pdfs/hospital-core-elements-H.pdf. Published 2019. Accessed February 20, 2024.Google Scholar
The Joint Commission. New and revised requirements addressing antibiotic stewardship for the hospital and critical access hospital programs: 2023. https://www.jointcommission.org/-/media/tjc/documents/standards/r3-reports/r3_antibioticstewardship_july2022_final.pdf. Published 2023. Accessed February 20, 2024.Google Scholar
Centers for Medicare and Medicaid Services. Infection prevention and control and antibiotic stewardship program interpretive guidance update. https://www.cms.gov/files/document/qso-22-20-hospitals.pdf. Published 2022. Accessed February 20, 2024.Google Scholar
Hoppes, M, Mitchell, J. Serious safety events: a focus on harm classification: deviation in care as link. Getting to zero white paper series - edition No. 2. American Society for Healthcare Risk Management (ASHRM). https://www.ashrm.org/sites/default/files/ashrm/SSE-2_getting_to_zero-9-30-14.pdf. Published 2014. Accessed February 19, 2024.Google Scholar
Duke Antimicrobial Stewardship Outreach Network. Developing patient safety outcome measures and measurement tools for antibiotic stewardship programs metrics guide. https://dason.medicine.duke.edu/sites/default/files/media-file/dason-cdcfinalanalysistool-r11-21.pdf. Published 2017. Accessed February 19, 2024.Google Scholar
Brotherton, AL. Metrics of antimicrobial stewardship programs. Med Clin North Am 2018;102:965–976.Google Scholar
File, TM Jr, Srinivasan, A, Bartlett, JG. Antimicrobial stewardship: importance for patient and public health. Clin Infect Dis 2014;15:S93–6.Google Scholar
Campbell, RE, Chen, CH, Edelstein, CL. Overview of antibiotic-induced nephrotoxicity. Kidney Int Rep 2023;8:2211–2225.Google Scholar
Baggio, D, Ananda-Rajah, MR. Fluoroquinolone antibiotics and adverse events. Aust Prescr 2021;44:161–164.Google Scholar
Boton, NH, Patel, PK, Kendall, RE, Hershey, C, Jarzebowski, M. Errors in perioperative antimicrobial use for hospitalized surgical patients. Antimicrob Steward Healthc Epidemiol 2022;2:e162.Google Scholar
Papan, C, Reifenrath, K, Last, K, et al. Antimicrobial use in pediatric oncology and hematology in Germany and Austria, 2020/2021: a cross-sectional, multi-center point-prevalence study with a multi-step qualitative adjudication process. Lancet Reg Health Eur 2023;28:100599.Google Scholar
Amaro-Hosey, K, Danés, I, Vendrell, L, et al. Adverse reactions to drugs of special interest in a pediatric oncohematology service. Front Pharmacol 2021;12:670945.Google Scholar
Majumdar, A, Shah, MR, Park, JJ, Narayanan, N, Kaye, KS, Bhatt, PJ. Challenges and opportunities in antimicrobial stewardship among hematopoietic stem cell transplant and oncology patients. Antibiotics 2023;12:592.Google Scholar
Tamma, PD, Aitken, SL, Bonomo, RA, et al. Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections, Clin Infect Dis 2023;ciad428.Google Scholar
Jenkins, TC, Tamma, PD. Thinking beyond the “core” antibiotic stewardship interventions: Shifting the onus for appropriate antibiotic use from stewardship teams to prescribing clinicians. Clin Infect Dis 2021;72:1457–1462.Google Scholar
Dubrovskaya, Y, Scipione, MR, Siegfried, J, et al. Multilayer model of pharmacy participation in the antimicrobial stewardship program at a large academic medical center. Hosp Pharm 2017;52:628–634.Google Scholar
Wirtz, AL, Burns, AN, Lee, BR, et al. Effectiveness and safety of mandatory antimicrobial indications and durations and a pharmacist-driven 48-hour time-out in a pediatric hospital. Am J Health Syst Pharm 2020;77:614–621.Google Scholar
Wirtz et al. supplementary material 1
Wirtz et al. supplementary material
File
23.4 KB
Wirtz et al. supplementary material 2
Wirtz et al. supplementary material
File
22.1 KB